Can I advertise kratom anywhere at all?

Not on the major auction platforms. Google Ads prohibits it under its recreational drugs and unapproved supplements policies, Meta bans it under the Drugs and Pharmaceuticals ad standard at its sole discretion, and TikTok prohibits drug ads across all markets. Certification doesn't unlock it — LegitScript runs a CBD certification track that opens limited inventory for compliant CBD topicals, but no kratom equivalent exists. What remains is everything you can own or earn: organic search, an opted-in email list, affiliate and content partnerships, newsletters and podcasts willing to carry the category, and retail relationships. That's not a consolation prize; it's where the durable kratom brands were built.

Does the DEA's 7-OH action ban kratom?

No. The July 1, 2026 notices of intent target 7-hydroxymitragynine above a defined threshold — 0.050% concentration or 1 mg per article — plus three related substances (mitragynine pseudoindoxyl, MGM-15, MGM-16). DEA states the action is not intended to capture botanical kratom leaf containing trace natural 7-OH. Practically: leaf powder and standard capsules with normal alkaloid profiles are outside the action's scope, while concentrated 7-OH tablets, gummies, and shots — the products FDA hit with warning letters in mid-2025 — are its explicit target. Per-lot COAs showing 7-OH content are now the document that determines which side of that line each SKU sits on. Track the Federal Register docket; temporary scheduling can finalize on short timelines.

I sell both kratom and delta-8/THCA products — what actually happens in November 2026?

The FY2026 appropriations act (P.L. 119-37, signed November 12, 2025) redefines federal hemp: the 0.3% limit becomes total THC including THCA rather than delta-9 alone, and finished consumable products are capped at 0.4 mg total THC per container. The changes take effect November 12, 2026, at which point most delta-8, delta-10, and THCA products on the market today fall outside the federal hemp definition. The Congressional Research Service has questioned how aggressively the government can enforce it — but processors, platforms, and landlords enforce faster than agencies do, and underwriting reviews will front-run the effective date. If both catalogs share one domain, separate the compliant lines from the sunsetting SKUs now and plan the redirect map so your search equity survives. Verify catalog decisions with counsel.

Kratom is legal in my state — why did my processor still shut me down?

Because processor rules are private contracts, not mirrors of state law. Stripe, Square, and PayPal write their prohibited categories around FDA status, card-network risk appetite, and their own exposure — and FDA's position that kratom cannot be lawfully marketed as a dietary supplement, backed by an import alert authorizing detention of shipments without physical examination, gives every risk team a documented basis to decline the category regardless of your state statute. The fix isn't arguing legality with a support queue; it's moving to an acquirer that underwrites kratom deliberately, presenting a site with clean claims and published COAs, and keeping a second rail live so a single risk-team decision can never take you offline.

Verticals / Kratom & Novel Cannabinoids

Kratom & Novel Cannabinoids

Every ad auction is closed to you. Your website, your rankings, and your list are the whole business — build them like it.

Kratom and novel cannabinoids are the most fully locked-out corner of American e-commerce. Google, Meta, and TikTok all prohibit the ads. Stripe, Square, and PayPal all decline the processing. The FDA maintains that kratom cannot be lawfully marketed as a dietary supplement and detains import shipments without physical examination. A rotating set of states ban the leaf outright while thirty-plus others regulate it under Kratom Consumer Protection Act frameworks with their own labeling, testing, and age rules. If you operate here, there is no paid funnel to optimize. Organic search, direct traffic, and an owned customer list are not a channel strategy — they are the entire company.

The 2025–2026 regulatory run made the ground rules sharper, not looser. FDA republished its kratom import alert in February 2025, then spent the summer of 2025 issuing warning letters over concentrated 7-hydroxymitragynine (7-OH) products and recommending they be scheduled. On July 1, 2026, DEA moved to temporarily place 7-OH above a defined threshold in Schedule I — explicitly carving out natural-leaf products with trace levels. Louisiana put kratom itself on its state Schedule I effective August 1, 2025. And for the novel cannabinoid side of the catalog, Congress redefined hemp in November 2025: on November 12, 2026, most delta-8, THCA, and similar intoxicating hemp products become federally unlawful. The operators who come through this are the ones with clean lab data, state-aware checkouts, and search positions competitors cannot buy their way into.

zsty builds websites and organic-growth programs specifically for verticals where the ad platforms have shut the door. What follows is the current platform, payments, and regulatory picture for kratom and novel cannabinoid operators — with primary sources — and how we approach building in it. This is operational and regulatory analysis, not legal advice; verify anything that touches your license or catalog with counsel.

Where the ad platforms stand

Google AdsBanned

Two policies close the door. Google's recreational drugs policy prohibits ads for substances taken to alter mental state, expressly including "legal highs" — the bucket kratom and intoxicating hemp cannabinoids fall into in practice. Its unapproved pharmaceuticals and supplements policy separately prohibits supplements containing active pharmaceutical or dangerous ingredients, and Google points advertisers to LegitScript's monitoring list. Kratom disapprovals typically surface as "Healthcare and unapproved substances." There is no certification path: LegitScript operates a CBD certification track that opens limited Google inventory for compliant CBD topicals, but no equivalent track exists for kratom or intoxicating cannabinoids. Repeat violations escalate to account suspension after a minimum 7-day warning.

policy source →

Meta (Facebook & Instagram)Banned

Meta's Drugs and Pharmaceuticals ad standard prohibits ads that promote the sale or use of "illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion." That discretionary clause is the operative part: kratom is not named, but Meta enforces against it as an unsafe substance, and there is no written exception, appeal category, or certification route. Enforcement reaches beyond ads — commerce surfaces (Facebook and Instagram Shops) exclude these products, and organic kratom content is subject to the Restricted Goods community standard. Attempting to run kratom offers through cloaked landing pages is the fastest way to lose the ad account and associated business assets.

policy source →

TikTokBanned

TikTok's advertising policies prohibit ads and landing pages that display, promote, or provide access to drugs — including recreational drugs — and drug paraphernalia, across every market and ad format. On the consumer side, kratom search terms are interstitial-gated with a substance-safety notice rather than product results, and promotional organic content is subject to removal under the Regulated Goods and Commercial Activities guidelines. There is no restricted-category application process for kratom or intoxicating hemp cannabinoids as there is for some other regulated goods.

policy source →

What closed paid channels do to the economics

When every auction is closed, customer acquisition cost stops being a bid and becomes an investment schedule. Paid CAC in an open vertical inflates every year as competition bids up the same inventory; organic CAC works the opposite way. Content production, technical SEO, and digital PR behave like capital expenditure — the cost per incremental customer falls as rankings, internal links, and brand queries compound. The catch is that the curve is front-loaded: you pay for twelve to eighteen months of building before search positions carry meaningful volume, and there is no ad budget you can pull forward to cover the gap. Brands that treat the website as a brochure while waiting for a paid channel to reopen are misreading the market — none of these platforms has loosened in the direction of kratom in a decade, and the 2025–2026 federal actions push the other way.

The second economic drag is payment infrastructure. High-risk processing means discount rates well above standard retail, rolling reserves that hold back a slice of revenue, and underwriting that can be revoked if dispute ratios climb — so chargeback risk management is a line item, not an afterthought. The realistic model absorbs elevated processing costs and state-by-state shipping exclusions through higher average order value, subscriptions, and owned-list retention. The compensation is a genuine moat: in an ad-open vertical a funded competitor can buy your customers tomorrow; here, nobody can outspend you into the rankings you already hold. Operators who built organic equity before the current crackdown own defensible share that new entrants now have to earn the slow way.

Compliance is site architecture

Catalog-level 7-OH screening with published lab data
DEA's July 2026 notices of intent draw the Schedule I line at 7-OH above 0.050% concentration or 1 mg per article, while explicitly stating the action is not intended to capture botanical leaf with trace natural levels. That makes per-lot certificates of analysis the load-bearing document for the whole business — for DEA exposure, for processor underwriting, and for buyer trust. Site architecture should make COAs crawlable, linked from every product page, and archived by lot, not buried in PDFs behind a form.
State-aware commerce: ship-to blocking and age gates
Kratom is banned outright in a set of states — Alabama, Arkansas, Indiana, Vermont, Wisconsin, and Louisiana as of August 1, 2025, plus county and city ordinances elsewhere — while KCPA states impose 21+ age limits, labeling, and testing rules. Checkout must enforce ship-to exclusions and age attestation programmatically, and the restrictions should be stated in plain copy before payment: a sale into a ban state is an unlawful transaction that puts the merchant account, not just the order, at risk.
Zero therapeutic claims anywhere a crawler can reach
FDA's position is that kratom is a new dietary ingredient without adequate safety evidence and cannot be lawfully marketed as a dietary supplement; its warning letters cite site copy, blog posts, testimonials, and metadata — not just labels. Product and category copy has to stay descriptive and operational: origin, alkaloid content, testing methodology, handling. Claims language doesn't just invite an FDA letter; it appears in every processor's underwriting review and every ad platform's landing-page scan.
Build to the strictest KCPA state you serve
More than a dozen states now run Kratom Consumer Protection Act regimes with divergent rules on labeling disclosures, alkaloid limits, age minimums, and registration. Maintaining fifty label variants is not realistic for most operators; the workable pattern is to treat the strictest state you actually ship to as the site-wide and label-wide baseline, and encode the exceptions in the shipping matrix rather than the copy.
Sequence the novel cannabinoid sunset before November 12, 2026
The FY2026 appropriations act (P.L. 119-37) redefines federal hemp to a total-THC standard including THCA and caps finished products at 0.4 mg total THC per container, effective November 12, 2026. Most current delta-8 and THCA SKUs become federally unlawful on that date. If those products share a domain with your compliant catalog, plan the content and URL transition now — 301 strategy, category consolidation, preserved link equity — so the domain's search authority survives the catalog turnover. Not legal advice; verify catalog decisions with counsel.

Payment infrastructure

Accept that mainstream processors are structurally closed
Stripe's prohibited list covers substances designed to mimic illegal drugs and "nutraceuticals and pseudo-pharmaceuticals" that are unsafe or make harmful claims — the categories under which kratom falls. Square's payment terms bar illegal goods and paraphernalia, and Square staff confirm in the Seller Community that kratom is unsupported. PayPal's Acceptable Use Policy reaches narcotics and other substances presenting consumer-safety risk, with violations exposing sellers to long fund holds and liquidated damages. Running kratom through a standard account under a mislabeled category ends in termination, frozen funds, and potential MATCH-list placement that follows the business.
Underwrite with a high-risk acquirer, on their terms
Specialized high-risk processors do board kratom merchants, but expect real underwriting: COA review, label review, claims review of the website, elevated rates, and a rolling reserve. The website is the underwriting file — the same disciplined copy and published lab data that keep FDA letters away are what get the merchant account approved and keep it alive at renewal.
Run redundant rails: card plus ACH/e-check
Kratom merchants live with single-point-of-failure risk on payments, and the 2025–2026 federal activity gives risk teams fresh reasons to re-review portfolios. The resilient posture is two live processing relationships plus an ACH or e-check option, with checkout built to fail over without code changes. Payment redundancy is cheaper than a single week of being unable to take orders.
Manage dispute exposure like the survival metric it is
High-risk merchant accounts die by dispute ratio. Clear billing descriptors, proactive shipping notifications, delivery confirmation, honest subscription terms, and a cancellation flow that works in under a minute keep dispute rates below network thresholds. In this vertical, retention UX is not just a growth lever — it is what keeps the processing relationship intact.
Let geography protect the merchant account
Processor risk teams check where you ship. Programmatic ship-to blocking for ban states, visible state-restriction copy, and logs proving enforcement are underwriting assets. The DEA 7-OH thresholds add a product dimension: acquirers are already distinguishing leaf and low-concentration products from extract-based 7-OH items, and catalogs carrying the latter should expect declines or carve-outs.

The zsty approach

zsty builds for verticals where the ad platforms have already said no. The method is not a workaround and it is not gray-hat — it is accepting that the website is the entire funnel and engineering it accordingly: technical SEO that survives algorithm updates, category and education architecture that ranks for the queries buyers actually type, COA and lab-data infrastructure that doubles as processor-underwriting evidence, state-aware checkout logic, and email capture that turns one ranking into a durable owned audience. In a vertical where nobody can buy traffic, the operator with the best-built site simply wins, and keeps winning, because the moat deepens with every month of published, indexed, linked work.

The method is proven on zsty's own properties in the hardest ad-banned vertical there is. zsty's founder operates Big Moose Hemp, a DTC hemp brand, under total ad prohibition — no Google, no Meta, no paid social, ever — and zsty.us itself ranks organically without a dollar of ad spend. We are not reselling a paid-media playbook with the ads deleted; we build businesses that were never allowed to run ads in the first place, and we carry the scars and the checklists from doing it on our own P&L.

For kratom and novel cannabinoid operators specifically, the 2025–2026 regulatory cycle is also a content strategy. Every scheduling notice, state bill, and federal redefinition generates search demand from confused buyers and retailers — and almost every page currently answering those queries is either a rehab-center lead magnet or a competitor's thin blog post. The brand that publishes accurate, plain-language, source-linked regulatory analysis becomes the destination for the exact audience it sells to. That is the flywheel we build: rankings bring the reader, lab data and disciplined copy earn the trust, and the owned list keeps the customer no platform will let you retarget.

Questions operators ask

Can I advertise kratom anywhere at all?: Not on the major auction platforms. Google Ads prohibits it under its recreational drugs and unapproved supplements policies, Meta bans it under the Drugs and Pharmaceuticals ad standard at its sole discretion, and TikTok prohibits drug ads across all markets. Certification doesn't unlock it — LegitScript runs a CBD certification track that opens limited inventory for compliant CBD topicals, but no kratom equivalent exists. What remains is everything you can own or earn: organic search, an opted-in email list, affiliate and content partnerships, newsletters and podcasts willing to carry the category, and retail relationships. That's not a consolation prize; it's where the durable kratom brands were built.
Does the DEA's 7-OH action ban kratom?: No. The July 1, 2026 notices of intent target 7-hydroxymitragynine above a defined threshold — 0.050% concentration or 1 mg per article — plus three related substances (mitragynine pseudoindoxyl, MGM-15, MGM-16). DEA states the action is not intended to capture botanical kratom leaf containing trace natural 7-OH. Practically: leaf powder and standard capsules with normal alkaloid profiles are outside the action's scope, while concentrated 7-OH tablets, gummies, and shots — the products FDA hit with warning letters in mid-2025 — are its explicit target. Per-lot COAs showing 7-OH content are now the document that determines which side of that line each SKU sits on. Track the Federal Register docket; temporary scheduling can finalize on short timelines.
I sell both kratom and delta-8/THCA products — what actually happens in November 2026?: The FY2026 appropriations act (P.L. 119-37, signed November 12, 2025) redefines federal hemp: the 0.3% limit becomes total THC including THCA rather than delta-9 alone, and finished consumable products are capped at 0.4 mg total THC per container. The changes take effect November 12, 2026, at which point most delta-8, delta-10, and THCA products on the market today fall outside the federal hemp definition. The Congressional Research Service has questioned how aggressively the government can enforce it — but processors, platforms, and landlords enforce faster than agencies do, and underwriting reviews will front-run the effective date. If both catalogs share one domain, separate the compliant lines from the sunsetting SKUs now and plan the redirect map so your search equity survives. Verify catalog decisions with counsel.
Kratom is legal in my state — why did my processor still shut me down?: Because processor rules are private contracts, not mirrors of state law. Stripe, Square, and PayPal write their prohibited categories around FDA status, card-network risk appetite, and their own exposure — and FDA's position that kratom cannot be lawfully marketed as a dietary supplement, backed by an import alert authorizing detention of shipments without physical examination, gives every risk team a documented basis to decline the category regardless of your state statute. The fix isn't arguing legality with a support queue; it's moving to an acquirer that underwrites kratom deliberately, presenting a site with clean claims and published COAs, and keeping a second rail live so a single risk-team decision can never take you offline.

zsty buys no ads. It ranks organically — and did so for itself first.

If paid acquisition is closed in your vertical, the owned layer is the whole game. That's the layer we build.

Start a conversation See the live SEO demo

Sources

Recreational drugs — Advertising Policies Help — Google
Unapproved substances — Advertising Policies Help — Google
Drugs and Pharmaceuticals — Ad Standards — Meta Transparency Center
Dangerous Products or Services — TikTok Advertising Policies — TikTok
Prohibited and Restricted Businesses — Stripe
Acceptable Use Policy — PayPal
Square Payment Terms — Square
Can I sell Kratom using Square? (staff-answered) — Square Seller Community
FDA and Kratom — U.S. Food & Drug Administration
FDA republishes import alert to detain kratom (Import Alert 54-15) — SupplySide Supplement Journal
FDA Announces Plan to Restrict 7-OH Opioid Products — Venable LLP
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I — Federal Register (DEA)
DEA to Temporarily Schedule 7-OH and Related Substances to Protect Public Safety — U.S. Drug Enforcement Administration
DEA to Temporarily Schedule 7-OH and Other Compounds Found in Kratom — Nutritional Outlook
New penalties for Kratom in effect Aug. 1 (Act 41 of 2025) — Louisiana Department of Revenue
Change to Federal Definition of Hemp and Implications for Federal Enforcement (CRS IN12620) — Congressional Research Service via Congress.gov
Shutdown Legislation Brings New Hemp Rules — Perkins Coie
2026 Federal Hemp Ban: What It Means for the Future of Consumable Hemp Products — Vicente LLP
Kratom FAQ — LegitScript
CBD Certification FAQs — LegitScript
Kratom 101: What You Need to Know — Association of State and Territorial Health Officials

Regulatory and platform policies change frequently. This page is operational analysis, not legal advice — verify current rules with counsel before acting.